Septicemia, access and cardiovascular disease in dialysis patients: The USRDS Wave 2 Study
Authors:
- Areef IshaniAIAreef Ishani
- Allan J. CollinsACAllan J. Collins
- Charles A. HerzogCHCharles A. Herzog
- Robert N. FoleyRFRobert N. Foley
- 1 July 2005
- journal article
- Published by Elsevier in Kidney International
- Vol. 68 (1) , 311-318
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Risk of Myocardial Infarction and Stroke after Acute Infection or VaccinationNew England Journal of Medicine, 2004
- Multiple Infections and Subsequent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) StudyCirculation, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Vascular access and increased risk of death among hemodialysis patientsKidney International, 2002
- Use of aStaphylococcus aureusConjugate Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 2002
- Type of vascular access and mortality in U.S. hemodialysis patientsKidney International, 2001
- A prospective study of vascular access infections at seven outpatient hemodialysis centersAmerican Journal of Kidney Diseases, 2001
- Atherosclerotic cardiovascular disease risks in chronic hemodialysis patientsKidney International, 2000
- Inflammation enhances cardiovascular risk and mortality in hemodialysis patientsKidney International, 1999
- Long-term vascular access for hemodialysis using silicon duallumen catheters with guidewire replacement of catheters for technique salvageAmerican Journal of Kidney Diseases, 1997